Abstract
T he reasons for applying disease management are different for the various players involved in the healthcare market. Delegates at an IIR Ltd conference on disease management in Europe heard Matthias Mangold from Bayer AV, The Netherlands, outline the problems of implementing disease management concepts and the needs of the different interest groups [ London, UK; December 1995 ].
Rights and permissions
About this article
Cite this article
Short, R. Disease management. Pharmacoecon. Outcomes News 46, 3–4 (1996). https://doi.org/10.1007/BF03269769
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03269769